A Mechanistic Target of Rapamycin (mTOR)-Inhibiting shRNA Delivered Intravitreally via rAAV as a Novel Therapeutic Strategy for Diabetic RetinopathySteven H. S. Lee,Joo Yong Lee,Hee Jong Kim,Jun-Sub Choi,Jin Kim,Ha-Na Woo,Keerang Park,Heuiran LeeMOLECULAR THERAPY(2020)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要